View document text
CITICHEM' INDIA LIMITED
512, Yogeshwar Premises, 5th Flocr, 135 Kazi Sayed Street, Masjid Bunder (W), Mumbai - 400 003
Email.: marketing@citichemindia.com Website : www.citichemindia.com Tel.: 022 - 49732489
CIN : U24100MH1992PLC065975 ISIN : INEOAB401016 GST No. 27AACCC9682M12Z
f5saf Central Lic. No. 11519018000620 State Lic. No 1020022010907 Pharma Lic. No. MH - TZS - 335245
Date: 14™ November, 2026
The Corporate Relationship Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai 400001.
Scrip Code: 544324
ISIN: INE0A8401016
Sub: Outcome of the Board Meeting held on 14 November, 2026.
Dear Sirs,
This is in reference to our earlier intimation dated 7% November, 2026, pursuant to Regulation 29 read with
Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), regarding holding of Board Meeting on 14%
November, 2026.
In this regard, please note that the Board of Directors at its meeting held today i.e 14% November, 2026 has inter
alia approved the Unaudited Financial Results of the Company for the half year ended 30 September, 2026.
Accordingly, we are enclosing herewith unaudited Standalone Financial Results for the half year ended 30%
September, 2026 along with Limited Review Report thereon.
The meeting of the Board of Directors of the Company commenced at 6: 00 p.m. and concluded at 8: 15 pm.
Kindly take note of the same.
For, CITICHEM INDIA LIMITED
Fhyad Shexn.
KHYATI PALASH SHETH
COMPANY SECRETARY
MEMBERSHIP NO.: ACS74357
NGST & Associates
Chartered Accountants
INDIA
Independent Auditor’s Review Report on Review of Interim Financial Results
To The Board of ctors of
Citichem India Limited
We have reviewed the accompanying statement of Unaudited Financial Results of Citichem India Limited (‘The
Company”) for the half year ended 30th September 2026 (‘the statement’), being submitted by the company pursuant
to the requirement of Regulation 33 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations,
2015.
This statement is the responsibility of the Company’s Management and has been approved by the Board of Directors
1 Committee of Board of Directors. Our responsibility is to issue a report on these financial statements based on our
review.
We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, ‘Review of Interim
Financial Information Performed by Independent Auditor of the Entity’ issued by the Institute of Chartered
Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to
whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of
company personnel & analytical procedures applied to financial data and thus provide less assurance than an audit.
We have not performed an audit and accordingly, we do not express an audit opinion.
Based on our review conducted as above nothing has come to our notice that causes us to believe that
the accompanying statement of unaudited financial results prepared in accordance with the applicable
Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013, read with
relevant rules issued thereunder and other accounting principles generally accepted in India has not
disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be
disclosed, or that it contains any material misstatement.
For NGST & Associates
Chartered Accountants
Firm'’s Registration No. 135159W
prupendd’
Bhupenddra Kumaar Gandhhi
Partner
Membership No. 122296
Date: 14/11/2026
UDIN: 26122296AJSIUW7528
Place: Mumbai
B/203|2™ Floor | Borivali Paras CHS |Rokadia Lane | Borivali (West)| Mumbai—400 092|
| E-mail: contact@ngstca.com | www.ngstca.com |
CITICHEM INDIA LIMITED
512, Yogeshwar Premises, 5th Floor, 135 Kazi Sayed Street, Masjid Bunder (W), Mumbai - 400 003
Email.: marketing@citichemindia.com Website : www.citichemindia.com Tel.: 022 - 48732489
CIN: U24100MH1992PLCO65975 ISIN : INEOAB401016 GST No. 27AACCC9682M12Z
Central Lic. No. 1513018000620 State Lic. No 1002002010807 Pharma Lic. No. MH - TZS - 335245
Citichem India Limited
Unaudited result for the period ended on 30 September 2026
(Rs. In Lakhs except for EPS)
For half year | For half year | For half year For the For the
Particulars ended ended ended year ended | year ended
30.09.2026 31.03.2026 30.09.2025 31.03.2026 | 31.03.2025
Income
Revenue from operations 22989 96.14 851.68 947 .82 1,869 54
Other operating income 118.58 371.62 158.32 529.94 3,567.89
Other income 1.00 349 66.81 70.29 36.05
Total Revenue 349.47 471.25 1,076.81 1,548.06 5,473.47
Expenses:
Purchase of stock - in - frade 135.51 9.36 1,085.72 1,095.07 1,817.59
g;‘:d"sges n inveritories of finished 47.42 202.83 (248.71) (45.88) | 312096
Employee benefits expense 35.84 8.68 12.78 21.46 29.11
Other Expenses 61.50 169.31 106.28 27559 299.22
Total Expenses 280.27 390.18 956.06 1,346.23 5,275.87
B e aaaion, 69.20 81.07 12075 201.82 197.60
peBredtaton and amorfsation 921 315 288 6.03 070
Finance Cost 251 31.89 26.47 58.37 3061
Profit/(Loss) before Tax 57.48 46.02 91.40 137.42 166.29
Tax expense
Current tax expense for current year 15.69 11.60 23.40 35.00 44.00
Deffered Tax (0.74) 228 - 228 (0.59)
Total Tax Expenses 14.95 13.88 23.40 37.28 43.41
Profit / (Loss) for the year 42.54 3214 68.00 100.14 122.87
Earnings per equity share: (Not Annualised for the half year ended)
(1) Basic 0.63 0.47 1.00 1.47 2.46
(2) Diluted 0.63 0.47 1.00 1.47 2.46
CITICHEM INDIA LIMITED
5§12, Yogeshwar Premises, 5th Floor, 135 Kazi Sayed Slreet, Masjid Bunder (W), Mumbai - 400 003
Email.: marketing@citichemindia.com Wabsite : www.citichemindia.com Tel.: 022 - 49732489
CIN : U24100MH1992PLCO85975 ISIN : INEDAB4D1016 GST No. 27AACCCO682M1ZZ
fozat Gentral Lic. No. 11519018000620 Stale Lic. No 1002022010907 Pharma Lic. No. MH - TZS - 335245
Notes:
1. The above unaudited Financial Results were reviewed by the Audit Committee and thereafter were approved by
the Board of Directors of the Company at its meeting held on 14 November 2026.
2. The segment-wise reporting as defined in AS-7 is not applicable since the Company has only one reportable
segment " Chemicals”
3. As per MCA Notification dated 16th February 2015, the companies whose shares are listed on BSE SME platform
as referred to in chapter XB of SEBI (Issue of Capital and Disclosure requirements) regulations, 2009 are
exempted from the Compulsory requirement of adoption of IND—AS. As the company is covered under exempted
from the Compulsory requirement of adoption of IND AS. Hence it has not adopted IND AS for preparation of
Financial Statements
4. Corresponding figures of the previous period have been re-grouped / re-aranged wherever necessary to make
them comparable.
For and On behalf of the Board of Citichem India Limited
Arif Merchant
Director
DIN No. - 00500363
Place: Mumbai
Date: 14 November 2026
CITICHEM INDIA LIMITED
512, Yogeshwar Premises, 5th Floor, 135 Kazi Sayed Street, Masjid Bunder (W), Mumbai - 400 003
Email.: marketing@citichemindia.com Wabsite : www.citichemindia.com Tel.: 022 - 48732489
CIN : U24100MH1992PLCO65975 ISIN : INEDAB4D1016 GST No. 27AACCCI682M12Z
f5saf Central Lic. No. 1151501800620 State Lic. No 1020022010907 Pharma Lic. No. MH - TZS - 335245
Citichem India Limited
Statement of assets and liabilities as at 30 September 2026
Rs. In Lacs
Eaticdlars o a0z | " Sroszome
EQUITY AND LIABILITIES ] ]
Shareholder's Funds
Share Capital 680.00 680.00
Reserves and Surplus 1,472.59 1,430.06
Non-Current Liabilities
Long-term borrowings - -
Deferred tax liabilities (net) 079 1.53
Current Liabilities
Short-term borrowings 0.01 772.08
Trade payables
- Micro, Small & Medium Enterprises 83.41 80.41
- Other than Micro, Small & Medium Enterprises 1,
[Showing first 8,000 characters — download PDF for full document]